Worldwide Pneumococcal Vaccine Industry to 2025 - Development of Protein-Based Combination Pneumococcal Vaccines Presents Opportunities
Segments Covered By Vaccine, Conjugate Vaccines are anticipated to account as the fastest-growing segment during the forecasted period. They are considered to be more robust over polysaccharide ones and hence are more preferred leading to high demand. It also covers a wide age group as it can vaccinate an infant from 6 weeks old to 5years of age and for people over 50 + age groups, reducing asymptomatic delivery of the bacteria, and thus resulting in marked group immunity. By Product Type, Prevnar-13 is estimated to account for the fastest-growing segment during the forecasted period as it is...